Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 236

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 236
---
 and dispositive power with regard to the shares directly held by FTV Fund IV and FTV Holdings. Mr. Bernstein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |

| (7) | Mr. Luo, a member of our Board, is an investor at ICONIQ Capital and may have limited partner or other                                                                                                     
 interests in one or more of the entities described in Note 13 below and disclaims beneficial ownership of the securities reported in FN13, except to the extent of his pecuniary interest therein, if any. |

| (8) | Includes (a) 37,810 shares of Enfusion Common Stock underlying stock options that are or will become                                                                               
 exercisable within 60 days of February 5, 2025 and (b) 106,921 shares of Enfusion Common Stock issuable upon the settlement of RSUs releasable within 60 days of February 5, 2025. |

| (9) | Based solely on information provided in a Schedule 13D filed with the SEC on June 23, 2023, as amended by                                                                                                                                               
 a Schedule 13D/A filed with the SEC on January 14, 2025. Consists of (a) 31,297,606 shares of Enfusion Common Stock held by FTV IV, L.P. (“FTV Fund IV”) and (b) 1,142,857 shares of Enfusion Common Stock held by FTV Investment                       
 Holdings, L.P. (“FTV Holdings”). FTV Management IV, L.L.C. (“FTV Management”) is the general partner of FTV Fund IV and FTV Management Company GP, L.L.C. (“FTV GP”) is the general partner of FTV                                                      
 Holdings and FTV Management. FTV GP exercises voting and dispositive power with regard to the shares held by FTV Fund IV and FTV Holdings and may be deemed the beneficial owner of such 31,297,606 shares of Enfusion Common Stock held by FTV Fund IV 
 and 1,142,857 shares of Enfusion Common Stock held by FTV Holdings. The address for each of FTV Fund IV, FTV Holdings, FTV Management and FTV GP is 535 Madison Avenue, Floor 33, New York, NY 10022.                                                   |

| (10) | Based solely on information provided in a Schedule 13G/A filed with the SEC on October 25,